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Abstract We previously identi¢ed wig-1 as a p53-induced
mouse gene that encodes a nuclear zinc ¢nger protein with un-
known function. To investigate whether wig-1 is a direct target
of p53-dependent transactivation, a DNA fragment correspond-
ing to the promoter region was cloned and sequenced. Three
regions containing consensus p53-binding sites were identi¢ed.
Two p53-binding motifs formed DNA^protein complexes with
p53 and were able to drive p53-dependent transcription in a
luciferase reporter assay. Our results demonstrate that wig-1
is a direct target of p53-mediated transcriptional transactiva-
tion. ( 2002 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The tumor suppressor p53 induces cell cycle arrest and/or
apoptosis in response to diverse cellular stress conditions such
as DNA damage, oncogene activation, hypoxia, and telomere
erosion (reviewed in [1,2]). More than half of all human tu-
mors carry mutated p53. This disrupts p53-induced apoptosis,
leading to genetic instability and selection for more malignant
variants. Tumors that retain wild-type (wt) p53 may fre-
quently carry other defects in the p53 pathway [3]. p53 null
mice develop normally in most cases, indicating that p53 is
not essential for embryonic development. However, p53 null
mice are highly tumor prone and develop lymphomas at an
early age [4], underscoring p53: s central role as tumor sup-
pressor.
p53 triggers its biological e¡ects by transcriptional trans-
activation of speci¢c target genes. This involves binding to a
conserved sequence site that consists of two copies of the 10
bp sequence 5P-PuPuPuC(A/T)(T/A)GPyPyPy-3P separated by
0^13 nucleotides [5]. A vast number of p53-regulated genes
have been identi¢ed. p21 encodes an inhibitor of cyclin-depen-
dent kinases that induces G1 cell cycle arrest. Bax, Noxa,
PUMA, and p53AIP1 [6^9] are all involved in cytochrome c
release from mitochondria during the initial steps of apopto-
sis. Genes involved in death receptor-mediated apoptosis, e.g.
Fas, KILLER/DR5 and PIDD, are also induced by p53 [10^
12]. Nevertheless, no single gene has so far been identi¢ed as
the main e¡ector of p53-dependent apoptosis. In addition to
genes involved in G1 arrest and apoptosis, p53 also induces
genes implicated in maintaining genomic integrity such as
Reprimo, Gadd45, and 14^3-3N [13,14] through induction of
G2/M arrest.
We have previously identi¢ed wig-1 as a gene upregulated
in response to activation of wt p53 [15]. wig-1 encodes a zinc
¢nger protein containing three zinc ¢ngers of the Cys2His2
type and a nuclear localization signal. We recently cloned
and characterized human wig-1. The overall amino acid iden-
tity between mouse and human wig-1 proteins is 87%. Human
wig-1 was shown to inhibit growth in a colony formation
assay [16].
To investigate the mechanism responsible for induction of
wig-1 mRNA by wt p53, we studied the interaction between
p53 and the mouse wig-1 promoter. Here we report the iden-
ti¢cation of three regions in the wig-1 promoter that contain
p53-binding motifs. Two of these regions were found to bind
to p53 in an electrophoresis mobility shift assay (EMSA) and
also to confer p53-dependent activation of a reporter plasmid
containing the wig-1 promoter. This demonstrates that wig-1
is a bona ¢de target gene of p53.
2. Materials and methods
2.1. Cloning of the wig-1 promoter
Mouse wig-1 genomic clones were isolated by screening a mouse
genomic lambda library (Strain 129Sv/Ola) in VFixII (provided by B.
Vennstro«m, Karolinska Institutet, Sweden), using the wig-1 open
reading frame (ORF) as a probe. A lambda clone that contained 5P
sequences of the wig-1 gene was sequenced with the forward primer
5F (5P-ACAATCAGCCTCCAGCAGCGG-3P) and the reverse primer
119R (5P-AACCCGAACCGGCAGGCC-3P), both located within
exon 1 of the wig-1 gene. A 1476bp PstI^XhoI fragment was cloned
into the pBluescriptIIKS vector (pBIIKSwig1promoter).
2.2. EMSA
Recombinant GST-p53 protein was expressed and puri¢ed from
Escherichia Coli as described [17]. The probes (see below) were 5P-
end labeled using T4 polynucleotide kinase (Invitrogen, The Nether-
lands) and [Q-32P]ATP (Amersham, Sweden). After labeling, the
probes were puri¢ed in a 20% native polyacrylamide gel and eluted
in 5 mM MgCl2. EMSA was performed using 50 ng of GST-p53
protein incubated with 0.3 ng probe and 0.3 Wg PAb421 monoclonal
antibody in binding bu¡er [20% Glycerol, 25 mM HEPES pH7.4, 50
mM KCl, 1 mg/ml bovine serum albumin, 0.05% Triton-X, 2 mM
MgCl2, 10 mM DTT] for 30 min at room temperature. Samples
were electrophoresed on a 4% native polyacrylamide gel, ¢xed in
10% ethanol/10% acetic acid for 10 min, dried and analyzed by auto-
radiography.
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Probes used for EMSA were BM1 (5P-AGGCCAGCCAGGGCCC-
AGCATGGTCCCAGCTTACAAGAGT-3P), BM2 (5P-ATACAAG-
TATTCACATGCAGAAGGTACAAGCCGGCAGAACAAGCTA-
3P), and BM3 (5P-CCGCTTGTCCGTGCACATGCGC-3P). Mutant
(mt) probes used for competition experiments were mtBM1 (5P-AGG-
ACATCCAGGGCCCAGAATTGTCCCAGCTAAAAATAGT-3P),
mtBM2 (5P-ATAAAATTATTCAAATTCAGAAGGTAAAATCCG-
GCAGAAAAATCTA-3P) and mtBM3 (5P-CCGATTTTCCGTGCA-
AATTCGC-3P).
2.3. Luciferase reporter constructs
Luciferase reporter constructs were made in pGL3basic (Promega,
WI, USA). The promoter fragments were subcloned from pBIIKS-
wig1promoter into the SmaI^XhoI sites in pGL3basic by cleavage at
the 5P end with the restriction enzymes shown in Fig. 3A, blunted with
Klenow and subsequently cleaved with XhoI. The BM3 deletion mt
(pGL3b-BM2vBM3) was made with the Transformer1 site-directed
mutagenesis kit (Clontech, CA, USA) using the deletion primer
5PGGTCTGCGGGAGCAGAGTAGCGCTGCCGGG-3P.
2.4. Cells and transfections
p533=3 mouse embryonic ¢broblasts (MEFs) were grown in IMDM
supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100
Wg/ml streptomycin, and 2 mM L-glutamine. Cells were transiently
transfected using LipofectAMINE2000 reagent (Invitrogen, The
Netherlands) according to the manufacturer’s instructions. Brie£y,
5U104 MEFs were plated in 24-well plates and transfected with 1 Wg
reporter constructs, 0.5 Wg pCMV-p53 or pCMV-p53(175) plasmid,
0.1 Wg pCMX-L-gal plasmid, and 2 Wl LipofectAMINE2000 per well.
pCMX-L-gal plasmid served as an internal control to correct di¡er-
ences in transfection e⁄ciency. Protein lysates were prepared 24 h
after transfection and assayed for luciferase activity using the Lucif-
erase Reporter Gene Assay High Sensitivity system (Roche Diagnos-
tics Scandinavia, Sweden) according to manufacturer’s description.
Light emission was detected by an Anthos Lucy3 luminometer.
3. Results
3.1. Cloning of the promoter region of wig-1
A genomic wig-1 clone was obtained by screening a mouse
genomic lambda library (mouse strain 129Sv/Ola) using wig-1
cDNA corresponding to the ORF as a probe. A 1.6 kb
EcoRI^BamHI fragment that hybridized with a probe corre-
sponding to wig-1 exon 1 and a 1.0 kb PstI^PstI fragment
that overlapped with the 5P end of the EcoRI^BamHI frag-
ment were cloned and partially sequenced. A PstI^XhoI frag-
ment derived from these two fragments was subcloned and
sequenced (GenBank accession number AF479745). This
1476 bp fragment contains 1342 bp upstream of the putative
exon 1 and 20 bp downstream (Fig. 1). Analysis of the se-
quence did not reveal any consensus TATA box. However,
two initiation regions (INR) that match the consensus se-
quence 5P-Py Py A(+1) N T/A Py Py-3P [18] were found.
One INR corresponds to the previously observed transcrip-
tion start site (TSS) of wig-1 [15]. The other INR, located 45
bp further upstream, corresponds the TSS found for the rat
wig-1 homologue PAG608 [19].
3.2. Identi¢cation of p53-binding motifs in the wig-1 promoter
Wt p53 expression results in a rapid induction of wig-1
mRNA, suggesting that wig-1 is a direct transcriptional target
of p53. Analysis of the sequence upstream of exon 1 revealed
three putative p53-binding motifs, here designated BM1,
BM2, and BM3 (Fig. 1). BM1 and BM2 were composed of
four decamer motifs corresponding to the consensus sequence
for p53 binding. Two decamers overlapped in BM1. BM3
contained two adjacent p53 decamers. All motifs had mis-
matches compared to the consensus sequence [5]. We also
identi¢ed three consensus Sp1 binding sites as well as three
consensus SOX binding sites in the wig-1 promoter. An addi-
tional Sp1 site was located in exon 1 (Fig. 1).
We performed EMSAs to determine if p53 could bind to
the putative p53-binding motifs. BM2 and BM3 formed p53
complexes (Fig. 2, lanes 6 and 10) that were e⁄ciently com-
peted out with excess of unlabelled probe (Fig. 2, lanes 7 and
11) but not with an excess of unlabelled mt probe (Fig. 2,
lanes 8 and 12). This indicates that p53 interacts speci¢cally
with these sites in the wig-1 promoter. BM1 formed a weak
complex with p53 (Fig. 2, lane 2) that was e⁄ciently competed
out by the mtBM1 probe (Fig. 2, lane 4), indicating that p53
binds unspeci¢cally to this site.
3.3. The wig-1 promoter is p53 responsive
To investigate the functional signi¢cance of the p53-binding
motifs, we constructed a luciferase reporter driven by the wig-1
promoter (pGL3b-wig1promoter) (Fig. 3A). The reporter was
Fig. 1. The promoter region of the mouse wig-1 gene. Exons are indicated as black boxes. Three putative p53-binding motifs were identi¢ed by
sequence comparison and designated BM1, BM2, and BM3 (shown as diamonds). The sequences of the p53-binding sites are shown with the
consensus decamers underlined. Mismatches from the consensus sequence are indicated by stars. The consensus sequence for p53 binding is
shown below. R indicates purine, Y pyrimidine, and W adenine or thymine. Putative Sp1 and SOX binding sites in the promoter are indicated
as un¢lled and ¢lled circles, respectively. Sp1 sites are located at nucleotides 31176 to 31171, 3726 to 3721, 3308 to 3303, and +91 to +96
relative to the TSS. SOX sites are located at nucleotides 3858 to 3850, 3602 to 3595, and 3365 to 3358 relative to the TSS.
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cotransfected with wt p53 or transcriptionally inactive mt
p53(175) [21] expression plasmids into p53 null MEFs. The
cells were harvested and assayed for luciferase activity 24 h
after transfection. A 12.5-fold induction was observed in cells
transfected with wt p53. Mt p53(175) failed to induce wig-1
promoter activity (Fig. 3B), thus indicating that a functional
p53 protein is required for transactivation of the wig-1 pro-
moter. The activity observed with mt p53(175) was approxi-
mately equal to that observed with empty vector (data not
shown).
3.4. Cooperation between p53-binding motifs
To study if all three p53-binding motifs contribute to the
activation of the wig-1 promoter, we generated a series of
luciferase reporter constructs containing di¡erent parts of
the wig-1 promoter (Fig. 3A). The reporters were cotrans-
fected and assayed for activity as above. The construct that
only contained BM3 (pGL3b-BM3) yielded a 4.6-fold induc-
tion with wt p53 as compared to pGL3b-TSS that lacks p53-
binding motifs but contains the putative transcription start
and exon 1 (Fig. 3B). The construct that also contained the
second p53-binding motif (pGL3b-BM2BM3) had an activity
close to the maximal activity observed with all three motifs
(pGL3b-wig1promoter) (Fig. 3B). Thus, BM1 did not signi¢-
cantly change the total p53-dependent activity of the wig-1
promoter. Therefore, we conclude that BM2 and BM3 are
the most important regions for p53-mediated induction of
wig-1 promoter activity.
To determine whether BM2 and BM3 act in a synergistic or
additive manner, we deleted BM3 in pGL3b-BM2BM3, keep-
ing the surrounding sequences intact (pGL3b-BM2vBM3).
With this construct we observed a 5.8-fold induction with
wt p53, approximately half of that observed for pGL3b-
BM2BM3 (Fig. 3B). Thus, it appears that BM2 and BM3
contribute equally to the p53-dependent promoter activity
and act in an additive manner.
4. Discussion
We have previously shown that wig-1 mRNA is upregu-
lated following p53 activation [15]. This suggested that
wig-1 is a direct transcriptional target of p53. To address
this question, we have cloned and partially characterized the
promoter region of wig-1. Three regions containing between
two and four decanucleotide motifs corresponding to the con-
sensus sequence for p53 binding were identi¢ed. Two of these,
BM2 and BM3, formed DNA^protein complexes with re-
combinant p53. These results were con¢rmed by luciferase
reporter assays in which both BM2 and BM3 contributed
signi¢cantly to p53-dependent transactivation. Thus, we con-
clude that wig-1 is directly transactivated by p53 and is a bona
¢de p53 target gene.
We observed a weak p53^BM1 complex that was fully com-
peted out by the mtBM1 probe, indicating unspeci¢c binding.
Moreover, BM1 had only a minor e¡ect in our reporter as-
says. The reason for the poor performance of BM1 is unclear.
This site contains four p53 consensus decanucleotide motifs,
two of which are overlapping. C and G at positions 4 and 7
are conserved in all four motifs (Fig. 1). It is noteworthy,
however, that two of the motifs in BM1 have mismatches
Fig. 2. EMSA showing binding of p53 to the p53-binding motifs in
the wig-1 promoter in vitro. Recombinant p53 protein (50 ng) incu-
bated with [K-32P]ATP-labeled oligonucleotides corresponding to the
three p53-binding sites. The p53^DNA complexes were resolved on
a 4% native polyacrylamide gel. For competition, 10-fold excess of
unlabeled oligonucleotides was added to the reactions. The p53 anti-
body PAb421 was added to activate recombinant p53.
Fig. 3. A: A schematic representation of the luciferase reporter con-
structs used. Restriction sites used for cloning are indicated. B:
p533=3 MEFs were cotransfected with 1 Wg of indicated luciferase
reporter and 0.5 Wg wtp53 (black) or mt p53(175) (gray) plasmid.
The data are representative of three independent experiments, each
performed in triplicates after normalization with L-galactosidase ac-
tivity and protein concentrations.
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within the core sequence C(A/T)(A/T)G of the consensus dec-
amer (C instead of A/T at position 5 of the decamer). In
contrast, the motifs in BM2 or BM3 only have mismatches
in the stretch of purines or pyrimidines at the beginning or the
end of the decamer. Crystal studies of a p53/DNA complex
have indicated that the core bases are critical for the interac-
tion between p53 and DNA [20].
The location of p53-binding motifs in target genes varies.
In, for example, the p21, MCK, MCG10, PERP and PTEN
genes [21^25], one or several p53-binding motifs are located in
the promoter region. p53-binding motifs can also be situated
in an intron, as in MDM2, Gadd45, and PUMA [8,26,27], or
in both the promoter and an intron, like in Cyclin G1 and
Bax [28,29]. With regard to the p53-binding motifs, wig-1
shares features with several other p53 target genes. The newly
identi¢ed MCG10 gene also has three p53-binding motifs in
its promoter [23], and like in wig-1 the most distal BM is not
functional. Two adjacent p53-binding sites, as in BM2 in the
wig-1 promoter, also appear in intron 1 of the MDM2 gene
[26]. It should be noted that mouse wig-1 may contain addi-
tional unidenti¢ed p53-binding sites in introns, as demon-
strated for several p53 target genes.
The presence of several p53-binding motifs in the wig-1
promoter may re£ect a rather complex transcriptional regula-
tion by p53 and its close relatives p63 and p73, both of which
have been shown to bind to the same consensus sequence as
p53 and upregulate several of the known p53 target genes
(reviewed in [30]). A recent study of the PERP promoter
showed that p63 binds both p53-binding sites present in the
promoter but more strongly to the 5P site, whereas p53 was
detected only at the 3P site after DNA damage [31]. It is
possible that £anking sequences determine the relative binding
a⁄nity of p53, p63, and p73 to the di¡erent sites in the pro-
moter, allowing ¢ne-tuned transcriptional regulation in re-
sponse to various stress-related and developmental signals.
Analysis of the promoter sequence of wig-1 may provide
further clues as to the possible involvement of other transcrip-
tion factors in regulation of wig-1 transcription. p53 uses Sp1
or an Sp1-related protein as a cofactor in order to achieve
maximal transactivation of the p21 and Bax promoters
[32,33]. Several GC-rich regions in the wig-1 promoter may
serve as Sp1 binding sites (Fig. 1). We have also identi¢ed
three putative binding sites for SOX (SRY-related HMG
box) proteins in the wig-1 promoter (Fig. 1). SOX proteins
play roles in a number of developmental processes, including
spermatogenesis, and several SOX proteins are expressed in
testis [34]. It is conceivable that SOX-dependent regulation of
transcription is responsible for the observed constitutive ex-
pression of wig-1 in adult mouse testis [15]. The functionality
of the putative Sp1 and SOX sites in the wig-1 promoter
remains to be proven experimentally. In any case, the cloning
and characterization of the mouse wig-1 promoter described
here should provide a basis for further studies of wig-1 regu-
lation and the biological function of wig-1.
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